In the pipeline: blockbusters to niche busters
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Presentation
- By: JøRGENSEN, Jan Trøst (Dx-Rx Institute, Fredensborg, Denmark)
The move toward a more individualized pharmacotherapy is inevitable. Our increased molecular understanding of the pathophysiology and the mechanisms of the drugs will enable us to develop more effective drugs in the future. The philosophy behind the individualized pharmacotherapy is that every patient has a unique biology and pathophysiology,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.